Isofol Medical AB ISOFOL

OMXSTO · Sweden · Health Technology

SEK 0.7500-0.01 (-1.32%)

Market closed· Oct 1, 2026, 3:29 PM UTC· SEK · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Isofol Medical AB ISOFOL

OMXSTO · Sweden · Health Technology

SEK 0.7500-0.01 (-1.32%)

Market closed· Oct 1, 2026, 3:29 PM UTC· SEK · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+10.29% · 6MFull-screen chart

Open SEK 0.7750High SEK 0.7790Low SEK 0.7440Close SEK 0.7500Volume 213.04K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: SEK 0.7600
Day range: SEK 0.7440 – SEK 0.7790
52-week range: SEK 0.5520 – SEK 0.9900
Volume: 213.04K
Market cap: SEK 243.57M
Next earnings date: 2026-11-12
Avg. volume (1Y): 768.23K

Performance

1 week

-6.17%

1 month

-3.43%

3 months

-0.65%

6 months

+17.47%

Year to date

+1.88%

1 year

-3.74%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Sweden
Exchange: OMXSTO
Shares outstanding: 320.49M
Employees: 6
ISIN: SE0009581051
Beta: 0.33

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceOct 09, 2025

IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer

GOTHENBURG, SWEDEN / ACCESS Newswire / October 9, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has appointed Gustaf Albèrt as the ...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.